Key result
Storage pool disease pigment mutants reduce platelet mepacrine uptake by >50% despite normal granule counts.
Why the study?
The dense granule defects in mouse pigment mutants with platelet storage pool disease were not fully characterized by previous electron microscopy studies.
The principal defect in mutant platelets of mouse models of platelet storage pool disease is an inability to accumulate dense granule contents rather than an absence of the granules.
Answers are grounded in this paper and cite their sources.
Challenges granule absence as core defect in storage pool disease; leaves open validation in human platelets and diagnostic assays.
Mepacrine uptake into platelets and bone marrow megakaryocytes was analyzed to further characterize the dense granule defects in a group of seven mouse pigment mutants that have characteristics of platelet storage pool disease (SPD). In contrast to our previous studies using electron microscopy, this method revealed that all mutants had normal numbers of dense granules. However, total mepacrine uptake in all mutant platelets was significantly diminished to less than 50% of normal uptake. Also, the flashing phenomenon observed when normal dense granules are irradiated with ultraviolet light was either greatly diminished or absent when platelets of individual mutants were similarly irradiated. Therefore the principal defect in the mutant platelets is an inability to accumulate dense granule contents rather than an absence of the granules. Mepacrine uptake into megakaryocytes was indistinguishable in normal and mutant mice. This indicates the mutant dense granule defects appear either very late in megakaryocyte development or early in platelet formation in correlation with development of the mature dense granule. By standard transmission electron microscopy we have not been able to detect gross structural or subcellular abnormalities in either platelets or megakaryocytes of mutant mice. It appears all seven mutants produce immature or functionally abnormal dense granules.
No takes yet. Share an insight, caveat, or question.
Reddington et al. (1987) studied Platelet storage pool disease (SPD) (n=7). Pigment mutation vs. Normal mice was evaluated on Total mepacrine uptake in platelets (<50% of normal uptake). Platelets from mouse pigment mutants with platelet storage pool disease exhibited normal numbers of dense granules but significantly diminished mepacrine uptake to less than 50% of normal.
Synapse has enriched 10 related papers. Consider them for comparative context: